Bishal Rajdev

机构：National Institute of Pharmaceutical Education and Research · ORCID：0000-0001-9644-2740

发表论文 28 篇 · 总被引 212 次 · h-index 8

代表论文

• AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma (2023 · JHEP Reports · 被引 29)
• Synthesis, in vitro, in silico and DFT studies of indole curcumin derivatives as potential anticancer agents (2022 · Journal of Molecular Structure · 被引 29)
• Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-κB axis (2023 · Clinical Science · 被引 28)
• Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis (2023 · International Immunopharmacology · 被引 26)
• AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis (2023 · Chemico-Biological Interactions · 被引 24)
• From co-delivery to synergistic anti-inflammatory effect: Studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in Complete Freund's Adjuvant induced arthritis rat model (2023 · International Journal of Biological Macromolecules · 被引 17)